AstraZeneca PLC (NASDAQ:AZN) Expected to Post Quarterly Sales of $11.16 Billion
Equities analysts expect that AstraZeneca PLC (NASDAQ:AZN – Get Rating) will report sales of $11.16 billion for the current quarter, according to Zacks. Two analysts have issued estimates for AstraZeneca’s earnings, with the highest sales estimate coming in at $11.21 billion and the lowest estimate coming in at $11.11 billion. AstraZeneca posted sales of $7.32 […]
Source: etfdailynews.com